LILRB1 Blockade Enhances Bispecific T Cell Engager Antibody–Induced Tumor Cell Killing by Effector CD8+ T Cells
Journal of Immunology - United States
doi 10.4049/jimmunol.1801472
Full Text
Open PDFAbstract
Available in full text
Date
June 28, 2019
Authors
Publisher
The American Association of Immunologists